Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDK4/6
Pharma
Novartis builds momentum with new drug launches
Novartis CEO Vas Narasimhan acknowledged that the company could have made its recent $23 billion U.S. investment plan sooner.
Angus Liu
Apr 29, 2025 10:52am
Kisqali off to a 'very rapid' launch in early breast cancer: CEO
Jan 31, 2025 11:28am
Pfizer's Ibrance scores in double-positive breast cancer
Dec 12, 2024 8:15am
Novartis pressures Lilly with Kisqali's broad breast cancer nod
Sep 17, 2024 3:04pm
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
May 23, 2024 5:00pm
ASCO: Novartis details Kisqali's adjuvant breast cancer win
Jun 2, 2023 8:00am
